Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phio Pharmaceuticals (PHIO) Cash from Financing Activities (2016 - 2021)

Historic Cash from Financing Activities for Phio Pharmaceuticals (PHIO) over the last 10 years, with Q4 2021 value amounting to -$1000.0.

  • Phio Pharmaceuticals' Cash from Financing Activities changed N/A to -$1000.0 in Q4 2021 from the same period last year, while for Dec 2021 it was $21.7 million, marking a year-over-year increase of 3466.0%. This contributed to the annual value of $4.0 million for FY2024, which is 4609.47% down from last year.
  • Phio Pharmaceuticals' Cash from Financing Activities amounted to -$1000.0 in Q4 2021.
  • Over the past 5 years, Phio Pharmaceuticals' Cash from Financing Activities peaked at $21.7 million during Q1 2021, and registered a low of -$74000.0 during Q3 2017.
  • Moreover, its 5-year median value for Cash from Financing Activities was $366000.0 (2017), whereas its average is $3.8 million.
  • Its Cash from Financing Activities has fluctuated over the past 5 years, first plummeted by 9960.6% in 2019, then soared by 4218888.89% in 2020.
  • Over the past 5 years, Phio Pharmaceuticals' Cash from Financing Activities (Quarter) stood at $366000.0 in 2017, then skyrocketed by 3558.47% to $13.4 million in 2018, then crashed by 94.28% to $766000.0 in 2019, then crashed by 102.22% to -$17000.0 in 2020, then surged by 94.12% to -$1000.0 in 2021.
  • Its Cash from Financing Activities stands at -$1000.0 for Q4 2021, versus $21.7 million for Q1 2021 and -$17000.0 for Q3 2020.